SkintThanks very much for your ‘non-expert’ assessment of the...

Skint
Thanks very much for your ‘non-expert’ assessment of the Pfizer trials and how SBP’s Coramsine compares. I appreciate you insights. You seem to have a relevant medical or scientific background.
Are you able to comment on:
- Whether the TGA ‘prescribed’ re-run trials are; planned/have been run/have been successful/are still in the pipeline of plans?
- Was it a term of the animal trials that they be done in secret and that SBP was prevented from announcing anything concerning them to the market until they had been signed off by the TGA?
- If the animal trials have been redone – have the results been forwarded to the TGA?
- If the rerun animal trials have not been started, why not? E.g. access to Lab space.
- Is it only, ‘appropriate results’ from the rerun animal trials that the TGA requires, before its gives the go ahead for the Phase two human trials?
- How much the Phase 2 trials will likely cost and whether the recent announcement re a private credit facility was in planning for this? Or are there other plans for this money?
- How many patients would likely be treated in the Phase 2 trials and over what period?
- Whether SBP are developing a second drug (from the Devil’s Apple) that they can use to ‘circumvent’ the delays imposed on Coramsine by the TGA or, whether any new drug(s) are unrelated?
- Whether Pfizer are likely to do the cost effective thing and either team with or, completely takeover Solbec.
If you have any other insightful observations that would be very much appreciated

Cheers

Kiwoz48